You are here : Home > Platforms > CMBA: Seeking Bioactive Molecules

Platforms & installations


CMBA: Seeking Bioactive Molecules

Published on 15 January 2020




The CMBA platform works in close collaboration with the DPM-Expert platform of the Department of Molecular Pharmacology (DPM) at Grenoble Alpes University, headed by Professor Ahcène Boumendjel. The DPM-Expert platform provides expertise in medicinal chemistry and collections of original chemicals, including extracts from alpine flora. Together, the two platforms constitute the Grenoble Alpes Drug Discovery (GAP2D) consortium, labeled by GIS-IBiSA pledge of open access and reliability for the acquisition, analysis and storage of data.

The CMBA is a member of the CHEMBIOFRANCE national infrastructure
The Center for the screening for BioActive Molecules (CMBA) of the BGE laboratory participates to the national infrastructure ChemBioFrance. This infrastructure was designed to encourage and stimulate exchanges and services at the interfaces between the chemistry of biology and chemoinformatics in order to select bioactive molecules that can be used for basic or therapeutic research purposes. ChemBioFrance is a distributed infrastructure that interconnects the French national chemical library, the platforms for the screening and the pharmacokinetic studies (ADME), and molecular modeling laboratories (chemoinformatics). It is open to researchers from academic and private laboratories.


CMBA: Seeking Bioactive Molecules

The Centre for Screening for Bio-active Molecules, is a pioneering Drug Discovery platform in Auvergne-Rhône-Alpes, member of the national infrastructure ChemBioFrance and the scientific interest group IBiSA.
It supports your academic or industrial research projects for the selection of bioactive molecules and drug candidates in all health sectors..

 Booklet as a pdf format

VideoRobot_CMBA.flv

ReportGal_CMBA
  • View in full screen
  • View in full screen
  • View in full screen
  • View in full screen